Familial Mediterranean Fever and Paget’s Disease: Incidental or Associated?

Abstract

Co-existence of Familial Mediterranean Fever(FMF) and Paget’s disease (PD)is very rare. In this paper, we aimed to present a case of FMF patient presenting with PD. A 62-year old male patient admitted with complaint of chronic low back pain and weight loss. An increased uptake at pelvis which was reported as paget metabolic bone disease was identified in bone scintigraphy. An infusion of 5 mg of zoledronic acid, calcium and Vitamin D treatments were administered. Paget’s disease (PD)is a rare condition in patients with FMF. The co-existence of FMF and PD should not be forgotten.

Keywords

• Familial Mediterranean Fever
• Paget
• Incidental
• Associated

References

1. 1. Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin. Immunol 2013;147:155-174.
2. 2. Portincasa P. Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare. Curr Med Chem 2016;23:60-86.
3. 3. Galson DL, Roodman GD. Pathobiology of Paget's disease of bone. J Bone Metabol 2014;21:85-98.
4. 4. Eekhoff EW, Karperien M, Houtsma D, et al. Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 2004;50:1650-1654.
5. 5. Albagha OM. Genetics of Paget's disease of bone. Bonekey Rep 2015;4:756.
6. 6. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64.
7. 7. Appelman-Dijkstra NM, Papapoulos SE. Paget's disease of bone. Best Pract Res Clin Endocrinol Metab 2018;32:657-668.
8. 8. Singer FR, Bone HG, Hosking DJ, et al. Paget’s disease of bone: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2014;99:4408-4422.

9. 9. Josse RB, Hanley DA, Kendler D, et al. Diagnosis and treatment of Paget’s disease of bone. Clin Invest Med 2007;30:E210-E223.
10. 10. Cundy T, Maslowski K, Grey A, et al. Durability of response to zoledronate treatment and competing mortality in Paget's disease of bone. J Bone Miner Res 2017; 32:753-756.
11. 11. Walsh JP: Paget’s disease of bone. Med J Aust 2004;181:262-265.
12. 12. Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 2008;112:1794-1803.